alexa David Goldenberg | Pennsylvania State University
ISSN: 2161-119X

Otolaryngology: Open Access
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

David Goldenberg

David Goldenberg David Goldenberg
Professor of Surgery and Oncology
Division of Otolaryngology-Head and Neck Surgery
Pennsylvania State University
USA
Biography

David Goldenberg is a Head and Neck Surgical Oncologist. He was educated at the Ben Gurion University in Israel. He completed a residency in Otolaryngology-Head and Neck Surgery at Rambam Medical Center in Haifa, Israel and then went on to do a three year fellowship in Head and Neck Surgery and Oncology at the Johns Hopkins Hospital in Baltimore. Currently a Professor of both Surgery and Oncology at the Penn State College of Medicine, he serves as the director of Head and Neck Surgery at the Penn State Hershey Medical Center and director of the Head and Neck Cancer Team at the Penn State Cancer Institute in Hershey, PA. He combines a surgical practice with teaching and research in head and neck and thyroid malignancies. Clinical expertise is in the surgical care of patients with head and neck cancer, thyroid cancer as well as parathyroid disease.

Dr. Goldenberg is the only head and neck surgeon in the region performing Da Vinci TransOral Robotic Surgery (TORS) and Minimally invasive radio guided parathyroidecotmy (MIRP). Research: Dr. Goldenberg is an NIH funded researcher and a prolific author of articles and books in the field of head and neck and thyroid oncology and surgery. His basic and translational research is in the field of Opioid Growth Factor (OGF) in thyroid cancer, and as a treatment for advanced head and neck cancer; BRAF mutation /P16 in Thyroid cancer; Tyrosine Kinase inhibitors and Advanced and recurrent Thyroid cancer

Research Interest

His basic and translational research is in the field of Opioid Growth Factor (OGF) in thyroid cancer, and as a treatment for advanced head and neck cancer; BRAF mutation/P16 in Thyroid cancer; Tyrosine Kinase inhibitors and Advanced and recurrent Thyroid cancer.

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords